Company News
BEXION appears on public television April 2009 NEW!
BEXION RECEIVES $500,000 matching funds from State of Kentucky March
2009 NEW!
BEXION RECEIVES 2008 PHASE 1 SBIR GRANT 1R43CA136017-01A1: "SapC-DOPS
Nanovesicles for Treating Glioblastoma Multiforme" NEW!
BEXION to appear on Sky Radio in August (May 2008)
BEXION partners with Molecular Targeting Technologies (MTTI) on
development of tumor diagnostics. April 2008
BEXION RECEIVES 2007 PHASE 1 SBIR GRANT R43CA130228-01: "A novel
biotherapeutic treatment for prostate cancer"
Series A closed on October 16, 2009 NEW!